Tomorrow.bio is a biotech company focused on cryonics and biostasis, offering whole-body and brain-only cryopreservation services with long-term Swiss storage. They emphasize advanced, data-driven approaches, state-of-the-art cryoprotection, and German-engineered equipment, backed by research, transparency, and a global perspective including US expansion. The organization aims to make biostasis accessible through membership models and financing options, while prioritizing safety, ethics, and measurable results for future revival possibilities.
No recent news for this company.
No recent deals for this company.